Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo
Authors:
- 27 July 2012
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 42 (11) , 1213-1220
Abstract
Eur J Clin Invest 2012; 42 (11): 1213–1220 Background Chemerin is an adipokine that regulates insulin sensitivity and insulin secretion. Prolonged hyperinsulinaemia is associated with higher systemic chemerin, and insulin induces adipose tissue chemerin release. These findings led us to hypothesize that systemic chemerin may be associated with post‐prandial glucose metabolism and/or may even be induced after oral glucose load. Therefore, the effect of insulin on adipocyte chemerin levels and systemic chemerin in mice was analysed. Further, systemic levels of chemerin after oral glucose load in nondiabetic individuals were studied.Design and methods Chemerin levels were determined in adipocytes after short‐term and long‐term treatment with insulin. Effects of acute hyperinsulinaemia were studied in mice. Chemerin was measured during oral glucose tolerance test in 66 healthy, nondiabetic individuals stratified for established body mass index categories.Results Insulin induces chemerin release from adipocytes within 24 h, while cellular levels are not affected. Short‐term hyperinsulinaemia also upregulates adipocyte chemerin in vitro but has no effect on adipose tissue and chemerin serum levels of mice. Systemic chemerin is higher in overweight/obese than normal‐weight controls and positively correlates with total cholesterol. Chemerin is not associated with markers of insulin sensitivity like fasting glucose or insulin. Fasting chemerin levels are similar to concentrations measured 1 and 2 h after oral glucose uptake in overweight and obese donors.Conclusions Post‐prandial hyperinsulinaemia does not contribute to higher chemerin levels in nondiabetic individuals.Keywords
This publication has 19 references indexed in Scilit:
- Sterol Regulatory Element-Binding Protein 2 (SREBP2) Activation after Excess Triglyceride Storage Induces Chemerin in Hypertrophic AdipocytesEndocrinology, 2011
- Chemerin: at the crossroads of inflammation and obesityTrends in Endocrinology & Metabolism, 2010
- Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat DietDiabetes, 2010
- Systemic chemerin is related to inflammation rather than obesity in type 2 diabetesClinical Endocrinology, 2010
- Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle CellsDiabetes, 2009
- Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosisEuropean Journal of Endocrinology, 2009
- Insulin and Metformin Regulate Circulating and Adipose Tissue ChemerinDiabetes, 2009
- Adipokines and Insulin ResistanceMolecular Medicine, 2008
- Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic SyndromeEndocrinology, 2007
- Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte MetabolismJournal of Biological Chemistry, 2007